Kohl's represents good value for patient investors, says RW Baird Baird believes Kohl's represents good value for patient investors citing low expectations and several credible initiatives that are poised to drive comp improvement in the second half of the year. Shares are Outperform rated with a $63 price target.
J.C. Penney downgraded to Sell from Neutral at UBS UBS downgraded its rating on J.C. Penney (JCP) shares to Sell saying the company's 2017 EBITDA target of $1.2B is overly optimistic as it assumes years of market share gains against strong competitors like Macy's (M) and Kohl's (KSS). UBS halved its price target for Penney shares to $5 from $10. The retailer's stock closed Friday down 52c to $7.12.